iPLEDGE Again On FDA Advisory Agenda, This Time As An Example

"REMS-related topics" is the theme of a joint FDA advisory committee meeting Dec. 1 focused on the landmark iPLEDGE program as an example of the effect such programs have on the health care system.

More from Archive

More from Pink Sheet